Medical Imaging

Medical Imaging is a $20 Billion per annum market which incorporates various modalities to discover the state of organs etc within the body without invasive procedures. These modalities are X-ray radiography, X-Ray Computed Tomography (CT), Ultrasound, Magnetic Resonance Imaging (MRI) and Nuclear Medicine, which involves placing radioisotopes at key areas within the body and detection gamma ray emission through Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). New modalities include Magnetic Particle Imaging and combining CT with MRI or PET. Increasingly these techniques are used to study the effectiveness of new pharmaceuticals.

SUPA has capability in new detectors and materials and works closely with SINAPSE. We have experts in computing, image recognition and data analysis. Additionally the SCAPA project is an exciting development that uses a laser plasma accelerator for use in particle beam therapy and to generate radioisotopes for imaging.

For more information, registered users can access our Medical Imaging Market Sector Report which examines the market and the unmet needs of the key companies in this area.